Journal
Information Content Entity
Continuant
Entity
Periodical
Generically Dependent Continuant
Collection
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer
Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer (SCLC): A Spanish Lung Cancer Group phase II study
FAC (fluorouracil, doxorubicin, cyclophosphamide) versus CMF (cyclophosphamide, methotrexate, fluorouracil) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group.
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small cell lung cancer: a spanish lung cancer group trial
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
Phase I/II trial of Irinotecan plus weekly 48-h continuous infusion of high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy of advanced colorectal cancer
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: Long-term results of the Spanish GCR-3 phase II randomized trial
RDF description of ANNALS OF ONCOLOGY - http://research.umh.es/vivo/pub/revista/0923-7534